| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/21/2004 | EP1408978A2 Novel phenylamino-pyrimidines and uses thereof |
| 04/21/2004 | EP1408919A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye |
| 04/21/2004 | EP0973750B1 Substituted benzimidazoles and their use for treating retroviral infection |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | EP0877736B1 Benzazepine derivatives with vasopressin agonistic activity |
| 04/21/2004 | EP0800831B1 Diagnostic marker |
| 04/21/2004 | CN1491226A Epindolidione pigments |
| 04/21/2004 | CN1491223A 3-indoline derivatives useful in treatment of psychiatric and neurologic disorders |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/20/2004 | US6723720 Pesticidal triazine-derivatives |
| 04/20/2004 | US6723445 Organic light-emitting devices |
| 04/20/2004 | CA2246485C Novel derivatives of indole and indazole, process for their preparation and pharmaceutical compositions containing them |
| 04/15/2004 | WO2004031401A2 Novel tyrosine kinases inhibitors |
| 04/15/2004 | WO2004031182A1 Piperazine derivatives and methods of use |
| 04/15/2004 | WO2004031180A1 Quinazolin-4-one derivatives |
| 04/15/2004 | WO2004031179A1 Indole-3-carboxamides as glucokinase (gk) activators |
| 04/15/2004 | WO2004031178A1 Pyrazole derivatives |
| 04/15/2004 | WO2004031176A2 Delta1 pyrrolines used as pesticides |
| 04/15/2004 | WO2004031174A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031150A1 Oxoammonium salts of 1-oxy-2,2,6,6-tetramethyl-1-piperidine (tempo) and their use as oxidizing agents |
| 04/15/2004 | WO2004030637A2 Treatment of obesity and other disorders associated with excessive food intake |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073039 Blocking neurotransmitter |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073035 Removal by salt formation |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072693 3-aminocarbonyl substituted benzoylpyrazolones |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2501502A1 Pyrazole derivatives |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | CA2499732A1 Piperazine derivatives and methods of use |
| 04/15/2004 | CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/14/2004 | EP1408032A2 Coupling product between tryptamine and an alpha-amino acid and its use in the field of neuro-cosmetics |
| 04/14/2004 | EP1407774A1 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1155012B1 Anti-cancer dihydroquinazoline derivatives |
| 04/14/2004 | EP1131297B1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2004 | EP1123703B1 Immunomodulatory drug composition |
| 04/14/2004 | EP0777656B1 Novel dna-targeted alkylating agents |
| 04/14/2004 | EP0706515B1 Intercalators having affinity for dna and methods of use |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1488630A Method for preparing triazole antifungal agent |
| 04/14/2004 | CN1488629A Method for preparing triazole antifungal agent |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720345 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720322 Use as endothelin receptor antagonists. |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720317 Inhibitors of factor Xa |
| 04/13/2004 | US6719520 For inhibition of glycogen synthase kinase-3 (gsk-3); treatment and prophylaxis for diabetes, chronic neurodegenerative conditions, mood disorders such as schizophrenia and manic depression and hair loss and cancer |
| 04/08/2004 | WO2004029051A1 Pyrazole amides for treating hiv infections |
| 04/08/2004 | WO2004029045A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | WO2004029044A1 Pyrimidine compounds as therapeutic agents |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029042A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 04/08/2004 | WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 04/08/2004 | WO2004029031A2 Therapeutic piperazine compounds |
| 04/08/2004 | WO2004029026A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2004016741A3 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
| 04/08/2004 | WO2004016604A3 Azabicyclic compounds are central nervous system active agents |
| 04/08/2004 | WO2004000227A3 Use of thio-oxindole derivatives in treatment of skin disorders |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003105854A3 Substituted dihydropyrimidines and dihydropyrimidinethiones as calcium channel blockers |